INTRODUTION
There are 15 Species in the genus Enterovirus, family Picornaviridae, order Picornavirales (http://www.picornaviridae.com/enterovirus/enterovirus.htm). Enterovirus Species C (EV-C) remains the type Species and Poliovirus (PV), the prototype member of the genus. Enteroviruses (EVs) have a naked capsid with icosahedral symmetry and a diameter of 28-30nM. The capsid encapsulates a positive sense, single-stranded RNA genome that is 7,500 nucleotides in length.
The genome has one open reading frame (ORF) that is flanked by untranslated regions on both ends. The ORF encodes one polyprotein that is autocatalytically cleaved to make 11 proteins; four structural proteins (VP1 -VP4) and seven non-structural proteins (2A-2C and 3A-3D).
Classically, EV identification was done by neutralization assays. However, since a correlation was shown to exist between serological types and VP1 sequence (Oberste et al., 1999) , VP1 amplification and sequencing became the standard for EV identification. Recently, the European Non-polio Enterovirus Network (ENPEN) recommended (Harvala et al., 2018) that in cases where VP1 data (or the full genome) is not available, VP2 and VP4 can be utilized for EV identification.
Most of the EV data available globally is courtesy the Global Polio Laboratory Network (GPLN); the laboratory arm of the Global Polio Eradication Initiative (GPEI). GPEI was established to eradicate PV globally and have so far reduced the incidence of poliomyelitis by >99.9% (Kew and Pallansch, 2018) . Their approach has so far included a blend of surveillance for PV (in acute flaccid paralysis [AFP] cases as well as in the environment) and vaccination (using both inactivated and live attenuated poliovirus vaccines) to interrupt PV transmission chains (Kew and Pallansch, 2018 ).
In the GPLN, PV detection is done using a cell culture-based algorithm that requires PV isolates to produce reproducible cytopathic effect (R-CPE) in RD and L20b cell lines (WHO, 2003 (WHO, , 2004 (WHO, , 2015 . The algorithm also results in the isolation of non-polio enteroviruses (NPEVs) which are also required to produce R-CPE in RD and/or L20b cell lines (WHO, 2003 (WHO, , 2004 (WHO, , 2015 . Samples with non-reproducible CPE (NR-CPE) are considered negative for EVs. This phenomenon of NR-CPE has been suggested to be caused by nonspecific cytotoxicity, Adenovirus or Reoviruses (to which the Rotaviruses belong) (WHO, 2007) . However, we (Adeniji et al., 2018) recently showed that EVs could also contribute to NR-CPE. In this study, we go a step further to find out how often the three (Adenoviruses, group A Rotaviruses and EVs) virus types are present in cell culture supernatants (CCS) recovered from L20b cell culture tubes with NR-CPE.
METHODS

Samples
Fifty-nine (59) cell culture supernatants (CCS) were analyzed in this study following the algorithm depicted in Figure 1 . All 59 CCS were recovered from L20b cell culture tubes with NR-CPE. The tubes had been previously inoculated with stool suspension from children (<15 years old) in Nigeria with acute flaccid paralysis (AFP). Prior this study, the samples were accumulated over the course of one (1) 
Adenovirus and Group A Rotavirus Screen
A rapid immunochromatographic test kit (Rotavirus Group A antigen/Enteric Adenovirus Antigen Rapid test kit, Accumed Technology Co. Ltd, Beijing) was used to screen the samples for Enteric Adenoviruses and Group A Rotavirus. As controls, a fecal suspension from a child with Rotavirus diarrhea that we had confirmed by molecular testing (unpublished data) and reference Adenovirus 1 and 6 from the BBSRC (a kind gift from Oladipo K.E.) were used as positive controls.
Passage in Hep2 Cell line
The HEp-2 cell line used in this study was maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 2% Fetal Calf Serum, 100IU/ml penicillin and 100mg/ml streptomycin. All CCS were passaged in HEp-2 cell line and incubated for 14 days at 37 0 C. -UTR and VP1) EV genomic regions were done in this study (Table   1 ). It is however crucial to mention that the VP1 assay is a semi-nested PCR assay with PE-VP1a
and PE-VP1b being the first and second round assays, respectively.
All primers used were made in 100µM concentrations. All PCR assays were done in 30µL volumes Table 1 . All PCR products were resolved on 2% agarose gels stained with ethidium bromide and viewed using a transilluminator.
Sanger Sequencing
Only the amplicons generated by the PE-VP1b assay (Table 1) were subjected to Sanger sequencing. The amplicons were shipped to Macrogen Inc, Seoul, South-Korea, where gel extraction and Sanger sequencing were done. Sanger sequencing was done using the primers AN89 and AN88.
Illumina Sequencing
For Illumina Sequencing, cDNA 1 was used. The genomes were amplified in overlapping fragments of 2 -3kb as previously described (Faleye et al., 2018a) . Irrespective of the intensity of amplicon or whether or not there were amplicons, for each isolate, the overlapping genomic fragments were pooled and shipped to a commercial facility (MR DNA, Texas, USA) where library preparation (Nextera DNA sample preparation kit), Illumina sequencing (paired end, 300
cycles, HiSeq) were done. The Illumina sequencing data was assembled using the Kiki assembler v0.0.9. Subsequently, detection of EV contigs was done using the Enterovirus Genotyping Tool 
Enterovirus identification and Nucleotide accession numbers
Enterovirus types were determined using the EGT v1.0 (Kroneman et al., 2011) . Nucleotide sequences generated in this study have been submitted to GenBank under the accession numbers MH607128, MK190417-MK190420.
Phylogenetic Analysis
All the sequences of the EV types of interest in GenBank were downloaded. Using the EGT v1.0 (Kroneman et al., 2011) , sequences that did not cover the VP1 region of interest were removed.
The sequences were then aligned using the ClustalW program in MEGA 5 software with default settings (Tamura et al., 2011) . Subsequently, neighbor-joining trees were constructed using 1000 bootstrap replicates (Tamura et al., 2011) . The accession numbers of sequences retrieved from
GenBank for analysis are shown in the phylograms. 
RESULTS
Adenovirus and Group A Rotavirus Screen
All the samples screened in this study were negative for the Enteric Adenovirus and Group A Rotavirus Screen (Figure 1) . However, the positive controls (a fecal suspension from a child with Rotavirus diarrhea and reference Adenovirus 1 and 6) were repeatedly and consistently detected by the rapid detection kit.
Passage in HEp2 Cell line
On passage in HEp2 cell line, only 4 (6.8%) of the 59 samples yielded isolates that were reproducible on passage in HEp2 cell line (Figure 1 ).
PCR assays
Three (75%) of the four isolates were positive for the PanEnterovirus 5-UTR (PE-5-UTR) assay. 
Sanger Sequencing
Of the two (2) samples positive for the PE-VP1 and shipped to the sequencing facility, only one was successfully sequenced. The other could not be sequenced due to insufficient volume. The sequenced isolate was typed as Echovirus 1 using the EGT (Table 2) .
Illumina Sequencing
This showed that isolates 1, 2 and 3 contained EV-D94, E1 and EV-D111 (Table 2) . Two contigs were assembled for each of isolates 1 and 3 while only one was assembled for isolate 2 ( Figure 2) .
A Glitch in the Enterovirus Genotyping Tool
It was observed that for isolate 3 (Table 2) , there was disparity in the genotype and serotype as determined by the EGT (Figure 2 ). In fact, there was also variation from one contig of isolate 3 to the other. To resolve this aberration and confirm the identity of isolate 3, nucleotide similarity between the VP1 sequence of isolate 3 (and other EV-D111 from GenBank) and a reference EV-D70 was estimated (Table 3 ). This confirmed that isolate 3 was indeed EV-D111. Furthermore, using the EGT to type the six (6) EV-D111 VP1 sequences available in GenBank, prior this study, showed that the aberration was not unique to isolate 3 ( Figure 3 )
Phylogenetic Analysis
Phylogenetic analysis showed that two (sub-Saharan Africa Phylogenetic analysis also showed that two (1 & 2) lineages of EV-D111 have been documented globally ( Figure 5 ). The EV-D111 lineage described in this study belongs to lineage 1 alongside those recovered in Cameroon and Central Africa Republic (CAF) ( Figure 5 ). It is crucial to mention that, prior this study, only six (6) EV-D111 sequences have been described till date and all were detected in sub-Saharan Africa ( Figure 6 ). The phylogenetic tree is based on an alignment of partial E1 VP1 sequences available in GenBank and those generated by our group. The E1 described in this study is indicated with a black triangle. Other previously unpublished E1 sequences we generated in 2012 were added. Bootstrap values are indicated if >50%. Note that while E1 was isolated on Hep-2 in this study, all the E1s we isolated in 2012 were recovered on LLC-MK2 cell line. Specifically, 5% (3/59) of the NR-CPE CCSs screened in this study had EVs that were missed by the RD-L20b (R-L) cell-culture-based algorithm (WHO, 2003 (WHO, , 2004 (WHO, , 2015 . We therefore confirm in this study that NR-CPE could sometimes be caused by EVs that possibly do not produce R-CPE in RD and L20b cell lines but do so in other cell lines like HEp-2. How often these EVs cause NR-CPE in R-L cell lines need further investigation. However, pending that, it seems 5% (this study)
to 30% (Adeniji et al., 2018) of CCSs from NR-CPE on R-L cell lines might contain EVs.
Three EVs (E1, EV-D111 and EV-D94) were identified in this study. While VP1 data was available to identify E1 and EV-D111, the EV-D94 isolate had no VP1 data available (figure 2).
It has been recommended (Harvala et al., 2018) and we have found it to be true (Adewumi et al., 2018 ) that in cases where VP1 data is not available, VP2 and VP4 can be utilized for EV identification. Hence, identification of the EV-D94 was done using a combination of the EGT and BLASTn result (data not shown). While the BLASTn result (data not shown) identified the isolate as EV-D94, the EGT could not assign it to any EV type using the VP2 and VP4 data. It however identified the isolate as EV-D94 using sequence data from the P3 genomic region, confirming the BLASTn result for the same region.
The EVs (E1, EV-D94 and EV-D111) described in this study (Table 2) are being described for the first time in Nigeria. In fact, should the information in GenBank and the Picornavirus Study Group website be real-time, as at the 4 th of November 2018, no complete genome of EV-D111 has been described and complete sequences exist for only the VP1 and VP4 genes. The EV-D111 sequence data we provide here, has the complete VP4, VP2, VP3, 2A, 2B, 2C, 3A and 3B genes ( Figure 2 ).
It also has partial sequences for 5-UTR, VP1 and 3C. Hence, some of the sequence data we provide for EV-D111 are being described for the first time globally. It is however, crucial to note that this valuable data would have been missed if the CCSs from these NR-CPEs had not been re-screened.
We believe, that as the EV community move more towards direct detection of EVs from samples , it is essential that the molecular epidemiology of this EV type be better investigated.
Currently, it seems the EGT is finding it difficult to type EV-D111. We first observed this with the EV-D111 isolate described in this study ( Figure 2 ). We consequently, checked all the six (6) EV-D111 strains described and available in GenBank prior this study and confirmed our observation ( Figure 6) . To be precise, using the capsid region data (P1), the EGT identifies EV-D111 strains as EV-D70 genotype and EV-D111 serological type ( Figure 6 ). It however does no such thing with E1 ( Figure 2 ). As at the time of writing this manuscript, EV-D70 and EV-D111 remain as independent EV types on the EV-D page of the Picornavirus Study Group website (http://www.picornaviridae.com/enterovirus/ev-d/ev-d.htm). It is therefore essential that the EGT software is checked to fix this glitch.
